Cynata Therapeutics achieves progress in stem cell technology – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics achieves progress in stem cell technology
Proactive Investors Australia Cynata Therapeutics (ASX:CYP) has received the Notice of Allowance from the U.S. patent office for a patent application tied to its proprietary Cymerus™ stem cell technology. This patent application covers an important element of Cynata’s stem cell … |
|
BRIEF-FDA approves Reneuron’s cryopreserved formulation of retinal stem cell therapy candidate
Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news … |
Contagionlive.com |
Could Immunotherapy Be Used to Tackle Antibiotic Resistance?
Contagionlive.com Lauri A. Hicks, DO, Director, Office of Antibiotic Stewardship, Centers for Disease Control and Prevention, discusses the use of immunotherapy in tackling antibiotic resistance. Interview Transcript (slightly modified for readability): “I think this is … |